These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33733079)

  • 1. A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome.
    Kruse RL; Barzi M; Legras X; Pankowicz FP; Furey N; Liao L; Xu J; Bissig-Choisat B; Slagle BL; Bissig KD
    JHEP Rep; 2021 Apr; 3(2):100252. PubMed ID: 33733079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.
    Kruse RL; Legras X; Barzi M
    Virus Res; 2021 Jan; 292():198224. PubMed ID: 33166564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.
    Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z
    Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
    Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
    J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cre/loxP-Based Recombinant HBV cccDNA System In Vitro and In Vivo.
    Zheng Y; Deng Q
    Methods Mol Biol; 2024; 2837():185-198. PubMed ID: 39044085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus.
    Zhou Z; Li C; Tan Z; Sun G; Peng B; Ren T; He J; Wang Y; Sun Y; Wang F; Li W
    Antiviral Res; 2023 Aug; 216():105642. PubMed ID: 37253400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
    Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
    Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Tu T; Zehnder B; Qu B; Urban S
    JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.
    Li G; Zhu Y; Shao D; Chang H; Zhang X; Zhou D; Gao Y; Lan K; Deng Q
    Hepatology; 2018 Jan; 67(1):56-70. PubMed ID: 28749559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
    Qu B; Nebioglu F; Leuthold MM; Ni Y; Mutz P; Beneke J; Erfle H; Vondran FWR; Bartenschlager R; Urban S
    JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models.
    Yi J; Lei X; Guo F; Chen Q; Chen X; Zhao K; Zhu C; Cheng X; Lin J; Yin H; Xia Y
    Antiviral Res; 2023 Jul; 215():105618. PubMed ID: 37142191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells.
    Wei L; Cafiero TR; Tseng A; Gertje HP; Berneshawi A; Crossland NA; Ploss A
    JHEP Rep; 2022 Sep; 4(9):100534. PubMed ID: 36035363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
    Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
    Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
    Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
    J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.